And Then There Were Five: Roche's Tecentriq Joins Europe I-O Race

 
• By Kevin Grogan
EU flag
Roche gets two approvals for Tecentriq - bladder and lung cancer • Source: Shutterstock

More from Immuno-oncology

More from Anticancer